Evidence map›Paper›PMID 26858838›Full record

ArticleNew microbes and new infections2016

First report of Oxa-72-producing Acinetobacter calcoaceticus in Lebanon.

A Al Atrouni, M Kempf, M Eveillard, R Rafei, M Hamze, M-L Joly-Guillou

Abstract read
In one paragraph

Article in New microbes and new infections, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A Al AtrouniLaboratoire Microbiologie Santé et Environnement (LMSE), Centre AZM pour la recherche en Biotechnologie et ses applications, Ecole Doctorale des Sciences et de Technologie, Université Libanaise, Tripoli, Lebanon; ATOMycA, Inserm Atip-Avenir Team, CRCNA, Inserm U892, 6299 CNRS, University of Angers, Angers, France.
M KempfATOMycA, Inserm Atip-Avenir Team, CRCNA, Inserm U892, 6299 CNRS, University of Angers, Angers, France; Laboratoire de Bactériologie, Institut de Biologie en Santé-Centre Hospitalier Universitaire, Angers, France.
M EveillardATOMycA, Inserm Atip-Avenir Team, CRCNA, Inserm U892, 6299 CNRS, University of Angers, Angers, France; Laboratoire de Bactériologie, Institut de Biologie en Santé-Centre Hospitalier Universitaire, Angers, France.
R RafeiLaboratoire Microbiologie Santé et Environnement (LMSE), Centre AZM pour la recherche en Biotechnologie et ses applications, Ecole Doctorale des Sciences et de Technologie, Université Libanaise, Tripoli, Lebanon; Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon.
M HamzeLaboratoire Microbiologie Santé et Environnement (LMSE), Centre AZM pour la recherche en Biotechnologie et ses applications, Ecole Doctorale des Sciences et de Technologie, Université Libanaise, Tripoli, Lebanon; Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon.
M-L Joly-GuillouATOMycA, Inserm Atip-Avenir Team, CRCNA, Inserm U892, 6299 CNRS, University of Angers, Angers, France; Laboratoire de Bactériologie, Institut de Biologie en Santé-Centre Hospitalier Universitaire, Angers, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emergence of carbapenem-resistant Acinetobacter spp. has been increasingly reported worldwide. We report here the first detection of an Acinetobacter calcoaceticus isolate from vegetables in Lebanon carrying the bla Oxa-72 gene. These findings show that the Lebanese environment may constitute a potential reservoir for this antibiotic resistance gene.

Indexed as

Acinetobacter calcoaceticusblaOxa-72carbapenem resistanceLebanonvegetables

Identifiers

PMID26858838
PMCPMC4706564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.